patent

Drug inventor report profiles individuals, US states, and countries leading pharmaceutical innovation

August 16, 2010

A new report from DrugPatentWatch.com profiles the leading researchers, US states, and countries responsible for drugs approved over the past ten years. The report features: Top Inventors Which inventors were granted the most patents? Patents per Inventor The patents awarded to each inventor Approved Drugs per Inventor The approved drugs protected by each inventor’s patents [...]

Read the full article →

India, Intellectual Property and Biotechnology Industry

December 3, 2009

This is a guest post from BiotechBlog reader Viren Konde. Do you have a response to Viren’s post? If so, you may respond in the comments section below. The recent editorial on “Intellectual property and biotechnology innovation: To protect or not protect” by Dr Yali Friedman, Managing Editor of the Journal of Commercial Biotechnology was [...]

Read the full article →

Biologic data exclusivity: The arguments for and against it

October 26, 2009

With the issue of data exclusivity for novel biologics re-emerging in the news, I’d like to present two arguments that will be published in the upcoming issue of the Journal of Commercial Biotechnology: Why data exclusivity is the new patent protection Peter J Pitts, Center for medicine in the public interest Follow-on biologic drug competition [...]

Read the full article →

Assessing India’s Innovation Climate

April 23, 2009

In 2005 India mostly strengthened their patent laws to meet international norms, with the distinct requirement that new drug products must “differ significantly in properties with regard to efficacy.” This requirement for a significant improvement in efficacy only applies to drugs — not to other patentable inventions like pens, car engines, etc., and is of [...]

Read the full article →

Drug Patent Expirations in December 2008

December 5, 2008

Courtesy of DrugPatentWatch.com: Drug Patent Expirations in December 2008 *Drugs may be covered by multiple patents

Read the full article →

Drug Patent Expirations in November 2008

November 3, 2008

Courtesy of DrugPatentWatch.com: Drug Patent Expirations in November 2008 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration ALKERAN Glaxosmithkline melphalan hydrochloride 4,997,651 Nov 18, 2008 BREVIBLOC Baxter Hlthcare Corp esmolol hydrochloride 5,017,609 Nov 21, 2008 BUSPAR Bristol Myers Squibb buspirone hydrochloride 5,015,646 Nov 14, 2008 COVERA-HS Gd Searle [...]

Read the full article →

Intellectual Property Theft on the Rise

October 14, 2008

Guest content from John Avellanet, managing director and principal of Cerulean Associates: Intellectual Property Theft on the Rise By John Avellanet, Managing Director and Principal of Cerulean Associates LLC Reprinted with permission from SMARTERCOMPLIANCE™ 2(9): p 1-2 (September 2008) Nine out of ten companies do not have appropriate policies and controls in place to stop [...]

Read the full article →

Drug Patent Expirations in October 2008

October 1, 2008

Courtesy of DrugPatentWatch.com: Drug Patent Expirations in October2008 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration CASODEX Astrazeneca bicalutamide 4,636,505 Oct 1, 2008 CONDYLOX Watson Pharms podofilox 5,057,616 Oct 15, 2008 COSOPT Merck dorzolamide hydrochloride; timolol maleate 4,797,413 Oct 28, 2008 ELIGARD Qlt Usa leuprolide acetate 4,938,763 Oct [...]

Read the full article →

Drug Patent Expirations in September 2008

September 2, 2008

Courtesy of DrugPatentWatch.com: Drug Patent Expirations in September 2008 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration ANDRODERM Watson Labs testosterone 4,855,294 Sep 6, 2008 AVITA Mylan Bertek tretinoin 5,045,317 Sep 3, 2008 DDAVP Sanofi Aventis Us desmopressin acetate 5,047,398 Sep 10, 2008 OPANA ER Endo Pharms oxymorphone [...]

Read the full article →

Drug Patent Expirations in August 2008

August 1, 2008

Courtesy of DrugPatentWatch.com: Drug Patent Expirations in August 2008 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration ADVAIR DISKUS 100/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 4,992,474 Aug 12, 2008 ADVAIR DISKUS 100/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 5,126,375 Aug 12, 2008 ADVAIR DISKUS 100/50 Glaxosmithkline fluticasone propionate; salmeterol [...]

Read the full article →

← Previous Entries